Daxor Debt to Equity Ratio 2010-2011 | DXR
Current and historical debt to equity ratio values for Daxor (DXR) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Daxor debt/equity for the three months ending December 31, 2011 was 0.00.
| Daxor Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2011-12-31 | $0.05B | $0.04B | 1.37 |
| 2011-09-30 | $0.05B | $0.04B | 1.35 |
| 2011-06-30 | $0.05B | $0.05B | 1.11 |
| 2011-03-31 | $0.05B | $0.05B | 1.01 |
| 2010-12-31 | $0.04B | $0.05B | 0.94 |
| 2010-09-30 | $0.04B | $0.05B | 0.79 |
| 2010-06-30 | $0.04B | $0.04B | 0.86 |
| 2010-03-31 | $0.04B | $0.05B | 0.87 |
| 2009-12-31 | $0.03B | $0.05B | 0.58 |
| 2009-09-30 | $0.03B | $0.05B | 0.58 |
| 2009-06-30 | $0.03B | $0.05B | 0.66 |
| 2009-03-31 | $0.03B | $0.03B | 0.95 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.038B | $0.000B |
| Daxor Corporation is a medical device manufacturing corporation with additional biotech services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $19.525B | 11.81 |
| Quest Diagnostics (DGX) | United States | $17.124B | 17.35 |
| DaVita (DVA) | United States | $12.715B | 16.44 |
| Encompass Health (EHC) | United States | $9.488B | 22.37 |
| Chemed (CHE) | United States | $7.824B | 24.05 |
| Elanco Animal Health (ELAN) | United States | $5.873B | 13.98 |
| RadNet (RDNT) | United States | $5.431B | 120.26 |
| Option Care Health (OPCH) | United States | $3.882B | 18.40 |
| LifeStance Health (LFST) | United States | $2.789B | 0.00 |
| Amedisys (AMED) | United States | $2.789B | 19.85 |
| Addus HomeCare (ADUS) | United States | $2.337B | 27.42 |
| Astrana Health (ASTH) | United States | $1.883B | 25.75 |
| U.S Physical Therapy (USPH) | United States | $1.362B | 35.82 |
| Pennant (PNTG) | United States | $0.925B | 37.42 |
| Aveanna Healthcare Holdings (AVAH) | United States | $0.854B | 0.00 |
| Atai Life Sciences (ATAI) | Germany | $0.206B | 0.00 |
| Bioqual (BIOQ) | United States | $0.059B | 0.00 |
| Ontrak (OTRK) | United States | $0.006B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.006B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.001B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |